Menu
Not yet recruiting NCT06981546

Modeling Clinical Outcomes in Gambling Addiction

Observational Gambling Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Gambling Disorder. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Gambling disorder (GD) is recognized as an addictive disorder. Financial consequences of GD are often dramatic, inducing professional, familial, legal and medical repercussions and particularly mental health consequences. MOGADOR is a longitudinal, multicentric, prospective, prognostic study, which aims to identify factors predicting the evolution of french patients with GD in care centers particularly involved in the management of GD. The main goal will focus on evolution of DSM-5 (Diagnostic and Statistical Manual of Mental Disorder 5th edition) GD criteria during the first year of follow-up. The prognostic factors will be collected at base-line and they will be considered to influence the long-term prognosis of patients. For patients suffering of GD, our main hypothesis is that initial factors like individual socio-demographic characteristics, clinical psychiatric profiles, addiction comorbidities, and behaviour are associated with the clinical prognosis (total remission of DSM-5 criteria of GD at 12 months). MOGADOR will be the first study, aiming to model prognostic aspects of GB in populations specially monitored for this disorder.

Primary outcome measures

  • Partial remission of gambling disorder at 12 months (strictly less than 4 DSM-5 criteria) [Time frame: DSM-5 criteria assessment will be conducted at 9 and 12 months after inclusion.]
  • modeling prognostic factors [Time frame: at inclusion visit.]

Eligibility criteria

Inclusion criteria

  • Patient, male or female, over 18 years old, consulting in one of the participating centers.
  • DSM-5 criteria for gambling disorder at inclusion: at least 4 criteria present in the 12 months preceding the study.
  • First treatment for gambling disorder or no treatment in the last 6 months (initiation or re-initiation of care).

Exclusion criteria

  • Unable to be reached by phone.
  • Unable to use the internet.
  • Patient under antiparkinsonian treatment of the dopaminergic family.
  • Being treated with a drug that may trigger/increase symptoms of gambling disorder (e.g. dopamine agonist).
  • Subject under guardianship.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 9 centers
  • Hôpital Jen Minjoz, CHU de Besançon — Besançon
  • Service Universitaire d'Addictologie de Lyon (SUAL), CH Le Vinatier — Bron
  • Service Universitaire d'Addictologie de Lyon (SUAL), Groupement Hospitalier Est — Bron
  • Service Universitaire d'Addictologie, CHU de Clermont-Ferrand — Clermont-Ferrand
  • Name of location * Service d'Addictologie, Groupe Hospitalier Seclin Carvin — Lille
  • Centre Expert Régional du Jeu Pathologique (CERJeP Limousin) — Limoges
  • Service Universitaire d'Addictologie, CHU de Nîmes — Nîmes
  • Assistance Publique des Hôpitaux de Paris, Hôpital Marmottan — Paris
  • … and 1 more center

Identifiers

NCT: NCT06981546 · 69HCL21_0270 · 2024-A01805-42

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗